James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

SHLD Stock: Sears CEO Eddie Lampert Is a Cheerleader, Not a Coach

The latest letter from Eddie Lampert about the future of Sears might excite some SHLD stock holders, but the message is starting to ring hollow.

Don’t Count on OTC Lipitor as an Rx for Higher PFE Stock

PFE stock holders are looking forward to cholesterol reducer Lipitor becoming an OTC drug, but Pfizer shareholders may have a long and disappointing wait.

New FDA Label Rules: Fear Not, Junk-Food Makers!

The recently proposed changes to FDA label rules for food and drink producers seems troubling for these food stocks, but...

Hate the Brand, Love the Stock

Contrary to popular belief, investing in a stock isn't a matter of morality or respect for fellow humans. It's all about the Benjamins, and these hated companies dole 'em out.

SHLD Stock: Don’t Focus on Earnings When Sears Reports Earnings

Here's what current and potential SHLD stock holders need to know about Thursday's Sears earnings report and conference call.